Prevalence of Misophonia in Turkish High School Students
ConditionMisophonia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15-18
SponsorOndokuz Mayıs University
About this trial
This cross-sectional study aims to determine the prevalence of misophonia among high school students in Kayseri and Samsun, Turkey. Data will be collected using a sociodemographic data form and the Amsterdam Misophonia Scale-Revised (AMISOS-R). The study will evaluate the frequency and severity of misophonia symptoms and examine their association with demographic variables.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Students enrolled in grades 9 through 12
Students without diagnosed hearing loss
Students without chronic illness
Students without severe psychological disorders
Disqualifiers
Students with diagnosed hearing loss
Students with any chronic illness
Students with severe psychological disorders
Students outside the defined age range
Trial population
High school students in grades 9 through 12 from selected schools in Kayseri and Samsun, Turkey.
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Prevalence of misophonia in high school students
The proportion of high school students identified as having misophonia based on predefined classification criteria using the Amsterdam Misophonia Scale-Revised (AMISOS-R). The AMISOS-R total score ranges from 0 to 40, with higher scores indicating greater misophonia severity. Misophonia classification is determined according to established cutoff values.
Time frame
Baseline (single assessment)Secondary outcomes
1
Severity levels of misophonia symptoms
Distribution of students according to misophonia severity levels (normal, mild, moderate, and severe) based on the Amsterdam Misophonia Scale-Revised (AMISOS-R). The AMISOS-R total score ranges from 0 to 40, with higher scores indicating more severe misophonia symptoms.
Time frame
Baseline (single assessment)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov